TSHA (Taysha Gene Therapies, Inc.) Stock Market Reviews

crown

search

Read and share opinions on TSHA (Taysha Gene Therapies, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mar

TSHA

Taysha Gene Therapies, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Citizens Lifts Price Target for Taysha Gene Therapies (TSHA)
Nov 8, 2025
Taysha Gene Therapies (TSHA): Revenue Forecast to Grow 70.49% Annually, Unprofitability Drives Debate
Nov 5, 2025
Taysha Gene Therapies Inc (TSHA) Q3 2025 Earnings Call Highlights: Strategic Advances and ...
Nov 4, 2025
Taysha Gene Therapies (TSHA): Assessing Valuation Following Strong Share Price Gains
Nov 4, 2025
Taysha Gene Therapies Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Nov 4, 2025
Taysha Gene Therapies to Release Third Quarter 2025 Financial Results and Host Conference Call and Webcast on November 4
Oct 28, 2025
Taysha Gene Therapies Regains Full Global Rights to Lead Rett Syndrome Program TSHA-102
Oct 26, 2025
Raymond James Initiates Strong Buy on Taysha (TSHA) Amid Rett Syndrome Trial Momentum
Oct 26, 2025
How Regaining Full Rights to Rett Syndrome Gene Therapy Has Changed Taysha (TSHA)’s Investment Story
Oct 18, 2025
Taysha Gene Therapies Regains Full Rights to Lead TSHA-102 Program in Clinical Evaluation for the Treatment of Rett Syndrome
Oct 16, 2025
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Oct 3, 2025
Piper Sandler Maintains a Buy on Taysha Gene Therapies (TSHA), Sets a PT of $9
Aug 26, 2025
Taysha Gene Therapies Inc (TSHA) Q2 2025 Earnings Call Highlights: Regulatory Milestones and ...
Aug 13, 2025

Reviews